Cargando…

Driver Mutations Dictate the Immunologic Landscape and Response to Checkpoint Immunotherapy of Glioblastoma

The composition of the tumor immune microenvironment (TIME) is considered a key determinant of patients’ response to immunotherapy. The mechanisms underlying TIME formation and development over time are poorly understood. Glioblastoma (GBM) is a lethal primary brain cancer for which there are no cur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yeo, Alan T., Shah, Rushil, Aliazis, Konstantinos, Pal, Rinku, Xu, Tuoye, Zhang, Piyan, Rawal, Shruti, Rose, Christopher M., Varn, Frederick S., Appleman, Vicky A., Yoon, Joon, Varma, Hemant, Gygi, Steven P., Verhaak, Roel G.W., Boussiotis, Vassiliki A., Charest, Al
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155040/ https://www.ncbi.nlm.nih.gov/pubmed/36881002 http://dx.doi.org/10.1158/2326-6066.CIR-22-0655

Ejemplares similares

Single-cell RNA sequencing reveals evolution of immune landscape during glioblastoma progression
por: Yeo, Alan T., et al.
Publicado: (2022)

Hiding in the dark: uncovering cancer drivers through image-guided genomics
por: Yoshihara, Kosuke, et al.
Publicado: (2014)

Immune-related adverse effects of checkpoint immunotherapy and implications for the treatment of patients with cancer and autoimmune diseases
por: Ibis, Betul, et al.
Publicado: (2023)

Immunotherapies for Malignant Glioma
por: Boussiotis, Vassiliki A., et al.
Publicado: (2017)

Chronic platelet-derived growth factor receptor signaling exerts control over initiation of protein translation in glioma
por: Zhou, Shuang, et al.
Publicado: (2018)

The evolving role of tissue-resident memory T cells in infections and cancer
por: Yenyuwadee, Sasitorn, et al.
Publicado: (2022)

Intragenic breakpoint: A marker of genome instability in glioblastoma
por: Zheng, Siyuan, et al.
Publicado: (2013)

Regulation of mRNA expression in breast cancer - a cis-tematic trans-action
por: Verhaak, Roel GW, et al.
Publicado: (2012)

Oncogenic drivers dictate immune control of acute myeloid leukemia
por: Austin, Rebecca J., et al.
Publicado: (2023)

Radiotherapy is associated with a deletion signature that contributes to poor outcomes in cancer patients
por: Kocakavuk, Emre, et al.
Publicado: (2021)

SHP-2 and PD-1-SHP-2 signaling regulate myeloid cell differentiation and antitumor responses
por: Christofides, Anthos, et al.
Publicado: (2022)

Effects of PD-1 Signaling on Immunometabolic Reprogramming
por: Boussiotis, Vassiliki A., et al.
Publicado: (2022)

Extrachromosomal DNA (ecDNA): an origin of tumor heterogeneity, genomic remodeling, and drug resistance
por: Pecorino, Lauren T., et al.
Publicado: (2022)

Beyond Precipitation: Physiographic Gradients Dictate the Relative Importance of Environmental Drivers on Savanna Vegetation
por: Campo-Bescós, Miguel A., et al.
Publicado: (2013)

Driver gene combinations dictate cutaneous squamous cell carcinoma disease continuum progression
por: Bailey, Peter, et al.
Publicado: (2023)

OTEH-10. Evolutionary trajectory of epigenomic of gliomas
por: Malta, Tathiane, et al.
Publicado: (2021)

The Dictator
Publicado: (1906)

Publisher Correction: Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cells
por: Bardhan, Kankana, et al.
Publicado: (2020)

Phosphorylation of PD-1-Y248 is a marker of PD-1-mediated inhibitory function in human T cells
por: Bardhan, Kankana, et al.
Publicado: (2019)

The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation
por: Bardhan, Kankana, et al.
Publicado: (2016)

Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin’s lymphoma with an emphasis on targeted therapies and transplantation strategies
por: Karantanos, Theodoros, et al.
Publicado: (2017)

Perspective of mesenchymal transformation in glioblastoma
por: Kim, Yona, et al.
Publicado: (2021)

Cavin-3 dictates the balance between ERK and Akt signaling
por: Hernandez, Victor J, et al.
Publicado: (2013)

Genetic context of oncogenic drivers dictates vascular sarcoma development in aP2‐Cre mice
por: Hanna, Jason A, et al.
Publicado: (2022)

Grammar dictation /
por: Wajnryb, Ruth
Publicado: (1990)

Comparison of gene expression patterns across twelve tumor types identifies a cancer supercluster characterized by TP53 mutations and cell cycle defects
por: Martínez, Emmanuel, et al.
Publicado: (2014)

Protein methyltransferases and demethylases dictate CD8+ T-cell exclusion in squamous cell carcinoma of the head and neck
por: Vougiouklakis, Theodore, et al.
Publicado: (2017)

Runx1 and Runx3 Are Involved in the Generation and Function of Highly Suppressive IL-17-Producing T Regulatory Cells
por: Li, Lequn, et al.
Publicado: (2012)

Epigenetic regulation of cancer biology and anti-tumor immunity by EZH2
por: Christofides, Anthos, et al.
Publicado: (2016)

Revisiting the PD-1 pathway
por: Patsoukis, Nikolaos, et al.
Publicado: (2020)

Commentary on: Combination of Metabolic Intervention and T Cell Therapy Enhances Solid Tumor Immunotherapy
por: Christofides, Anthos, et al.
Publicado: (2021)

The landscape and therapeutic relevance of cancer-associated transcript fusions
por: Yoshihara, Kosuke, et al.
Publicado: (2014)

Dimerization dictates the message
por: Short, Ben
Publicado: (2015)

The Dictator of Medical Ethics
Publicado: (1909)

Regulation of T Cell Differentiation and Function by EZH2
por: Karantanos, Theodoros, et al.
Publicado: (2016)

Corrigendum: Regulation of T Cell Differentiation and Function by EZH2
por: Karantanos, Theodoros, et al.
Publicado: (2016)

The effect of oligonucleotide microarray data pre-processing on the analysis of patient-cohort studies
por: Verhaak, Roel GW, et al.
Publicado: (2006)

Listening dictation : understanding English sentence structure /
por: Morley, Joan
Publicado: (1976)

A PDGFRα-driven mouse model of glioblastoma reveals a stathmin1-mediated mechanism of sensitivity to vinblastine
por: Jun, Hyun Jung, et al.
Publicado: (2018)

A B cell-derived gene expression signature associates with an immunologically active tumor microenvironment and response to immune checkpoint blockade therapy
por: Varn, Frederick S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9pi46muicvnnn2mss6kqtnj81c